AI SYSTEM SPOTS PANCREATIC CANCER 475 DAYS EARLY

Pancreatic cancer typically has poor outcomes due to late detection, with most patients diagnosed at advanced stages. Redmod analyzes standard imaging scans to identify tumors years earlier than conventional methods, potentially allowing intervention during more treatable phases. The system represents a significant advance in using machine learning for early cancer detection. By processing routine CT scans already being performed for other reasons, Redmod provides an opportunity to catch pancreatic cancer incidentally—without additional imaging procedures or screening protocols. Researchers at Mayo Clinic have not yet released detailed findings on accuracy rates or the size of the study population. The work builds on broader efforts to deploy AI in radiology for improved diagnostic capabilities. Early detection of pancreatic cancer remains a critical challenge, as the disease is often asymptomatic in early stages. If validated in larger studies, Redmod could become a standard tool in clinical settings, potentially improving prognosis for thousands of patients annually.